Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness

Biochemical and Biophysical Research Communications

Volumn 320, Issue 4, 2004, Pages 1096-1102

  Duxbury, Mark S ^a   Ito, Hiromichi ^a   Zinner, Michael J ^a   Ashley, Stanley W ^a   Whang, Edward E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Cancer; EphA2; Ephrin A1; Focal adhesion kinase; Invasion; Pancreatic; Tyrosine kinase

Indexed keywords

EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A2; GELATINASE A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; ENZYME DEGRADATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL;

ADENOCARCINOMA; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; EPHRIN-A1; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; MATRIX METALLOPROTEINASE 2; PANCREATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPHA2; RECOMBINANT FUSION PROTEINS;

EID: 3142677219     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.054     Document Type: Article

References (38)

1. Himanen J.P., Nikolov D.B. Eph receptors and ephrins. Int. J. Biochem. Cell Biol. 35:2003;130-134
2. Wilkinson D.G. Eph receptors and ephrins: regulators of guidance and assembly. Int. Rev. Cytol. 196:2000;177-244
3. Holder N., Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development. 126:1999;2033-2044
4. Flenniken A.M., Gale N.W., Yancopoulos G.D., Wilkinson D.G. Distinct and overlapping expression patterns of ligands for Eph-related receptor tyrosine kinases during mouse embryogenesis. Dev. Biol. 179:1996;382-401
5. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., Henkemeyer M., Strebhardt K., Hirai H., Wilkinson D.G., Pawson T., Davis S., Yancopoulos G.D. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 17:1996;9-19
6. Kinch M.S., Carles-Kinch K. Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin. Exp. Metastasis. 20:2003;59-68
7. Walker-Daniels J., Hess A.R., Hendrix M.J., Kinch M.S. Differential regulation of EphA2 in normal and malignant cells. Am. J. Pathol. 162:2003;1037-1042
8. Duxbury M.S., Ito H., Zinner M.J., Ashley S.W., Whang E.E. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene. 23:2004;1448-1456
9. Carles-Kinch K., Kilpatrick K.E., Stewart J.C., Kinch M.S. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res. 62:2002;2840-2847
10. Carter N., Nakamoto T., Hirai H., Hunter T. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat. Cell Biol. 4:2002;565-573
11. Miao H., Burnett E., Kinch M., Simon E., Wang B. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2:2000;62-69
12. Miao H., Wei B.R., Peehl D.M., Li Q., Alexandrou T., Schelling J.R., Rhim J.S., Sedor J.R., Burnett E., Wang B. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell Biol. 3:2001;527-530
13. Zantek N.D., Azimi M., Fedor-Chaiken M., Wang B., Brackenbury R., Kinch M.S. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ. 10:1999;629-638
14. Pandey A., Shao H., Marks R.M., Polverini P.J., Dixit V.M. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science. 268:1995;567-569
15. Pandey A., Lazar D.F., Saltiel A.R., Dixit V.M. Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity. J. Biol. Chem. 269:1994;30154-30157
16. Sun F.X., Tohgo A., Bouvet M., Yagi S., Nassirpour R., Moossa A.R., Hoffman R.M. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 63:2003;80-85
17. Koshiba T., Hosotani R., Wada M., Miyamoto Y., Fujimoto K., Lee J.U., Doi R., Arii S., Imamura M. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer. 82:1998;642-650
18. Ellenrieder V., Alber B., Lacher U., Hendler S.F., Menke A., Boeck W., Wagner M., Wilda M., Friess H., Buchler M., Adler G., Gress T.M. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer. 85:2000;14-20
19. Zhang Y., Thant A.A., Hiraiwa Y., Naito Y., Sein T.T., Sohara Y., Matsuda S., Hamaguchi M. A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. Biochem. Biophys. Res. Commun. 290:2002;1123-1127
20. Sein T.T., Thant A.A., Hiraiwa Y., Amin A.R., Sohara Y., Liu Y., Matsuda S., Yamamoto T., Hamaguchi M. A role for FAK in the concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene. 19:2000;5539-5542
21. Walker-Daniels J., Riese D.J., Kinch M.S. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol. Cancer Res. 1:2002;79-87
22. Langdon W.Y. The cbl oncogene: a novel substrate of protein tyrosine kinases. Aust. N.Z. J. Med. 25:1995;859-864
23. Miyake S., Lupher M.L. Jr., Druker B., Band H. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. Proc. Natl. Acad. Sci. USA. 95:1998;7927-7932
24. Hauck C.R., Hsia D.A., Puente X.S., Cheresh D.A., Schlaepfer D.D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21:2002;6289-6302
25. Zelinski D.P., Zantek N.D., Stewart J.C., Irizarry A.R., Kinch M.S. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res. 61:2001;2301-2306
26. Walker-Daniels J., Coffman K., Azimi M., Rhim J.S., Bostwick D.G., Snyder P., Kerns B.J., Waters D.J., Kinch M.S. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate. 41:1999;275-280
27. Rosenberg I.M., Goke M., Kanai M., Reinecker H.C., Podolsky D.K. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am. J. Physiol. 273:1997;G824-G832
28. Easty D.J., Guthrie B.A., Maung K., Farr C.J., Lindberg R.A., Toso R.J., Herlyn M., Bennett D.C. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res. 55:1995;2528-2532
29. Lu M., Miller K.D., Gokmen-Polar Y., Jeng M.H., Kinch M.S. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity. Cancer Res. 63:2003;3425-3429
30. M.S. Duxbury, H. Ito, M.J. Zinner, S.W. Ashely, E.E. Whang, FAK gene silencing promotes caspase-mediated anoikis in pancreatic adenocarcinoma cells, Surgery In press (2003)
31. Duxbury M.S., Ito H., Benoit E., Zinner M.J., Ashley S.W., Whang E.E. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. 311:2003;786-792
32. Frisch S.M., Vuori K., Ruoslahti E., Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134:1996;793-799
33. Gabarra-Niecko V., Schaller M.D., Dunty J.M. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev. 22:2003;359-374
34. Golubovskaya V.M., Gross S., Kaur A.S., Wilson R.I., Xu L.H., Yang X.H., Cance W.G. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. 1:2003;755-764
35. Hauck C.R., Hsia D.A., Schlaepfer D.D. The focal adhesion kinase - a regulator of cell migration and invasion. IUBMB Life. 53:2002;115-119
36. Kornberg L., Fleigel J. The effects of inducible overexpression of FAK-related non-kinase (FRNK) on a transformed epithelial cell line. Anticancer Res. 23:2003;91-97
37. Kornberg L.J. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck. 20:1998;745-752
38. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., Liu E.T., Cance W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55:1995;2752-2755